Login
Dr Desai’s was the Director of Rheumatology and Oncology at SmithKline Beecham and Global Clinical Director at Aventis Pharmaceuticals before becoming the Vice President of Pre-Clinical and Clinical Research at Neose Technologies, and Chief Medical Officer of Biotherapharma. He founded International Medical Consultants and IMC Radiology in 2006. He co-founded Omega Solutions in 2011 and was successful in exiting for a 20x profit in 2016.
Dr Desai is also an active writer for investment websites (previously for TheStreet.com, and presently with SeekingAlpha.com) and is a published author (Germs of War). He is a speaker at various medical and business conferences and was a medical advisor to ABC News on bioterrorism
Specialties: Assessment Read more
Assessment of overall company strategy and pre-clinical/clinical plans. Due diligence and evaluation of in-licensing compounds. Planning and executing studies in pre-clinical pharmacology and toxicology,. Planning and executing studies in clinical research including writing clinical protocols, clinical development plans, medical monitoring, writing ISS/ISE. Regulatory guidance, filing IND/NDA/BLA, marketing support, publishing in journals. Therapeutic areas include immunology, rheumatology, pulmonary, metabolism, neurology, oncology, vaccines, ID.
• Wyeth
• Astra Zeneca
• US Government DoD
• Novartis
• Medimmune
• Curry Pharmaceuticals
• Pinnacle Therapeutics
• Metastatix
• Azenvan Pharmaceuticals
• Sirtex Technologies
• Oncoceutics
